Dr. Reddy’s Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
Dr. Reddy’s becomes the first company to receive marketing authorization for generic Semaglutide Injection in Canada The market authorization was granted to Dr. Reddy’s ahead of Health Canada’s review target date HYDERABAD, India & MISSISSAUGA, Ontario — Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.